ES2184948T3 - Capsulas que contienen diclofenaco o sus sales en forma de solucion. - Google Patents
Capsulas que contienen diclofenaco o sus sales en forma de solucion.Info
- Publication number
- ES2184948T3 ES2184948T3 ES97118047T ES97118047T ES2184948T3 ES 2184948 T3 ES2184948 T3 ES 2184948T3 ES 97118047 T ES97118047 T ES 97118047T ES 97118047 T ES97118047 T ES 97118047T ES 2184948 T3 ES2184948 T3 ES 2184948T3
- Authority
- ES
- Spain
- Prior art keywords
- diclofenaco
- salts
- solution
- capsules containing
- polystophyled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 title abstract 3
- 239000002775 capsule Substances 0.000 title abstract 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 2
- 108010010803 Gelatin Proteins 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
LA INVENCION SE REFIERE A CAPSULAS HECHAS DE GELATINA BLANDA O DURA QUE CONTIENEN COMO PRINCIPIO ACTIVO EL FARMACO ANTIINFLAMATORIO CONOCIDO COMO DICLOFENACO (INN) O LAS SALES SODICAS, POTASICAS O DE HIDROXIETILPIRROLIDINA DE AQUEL DISUELTAS EN UN SOLVENTE SELECCIONADO ENTRE POLIETILENGLICOLES, GLICERIDOS POLIGLICOSILADOS SATURADOS C SUB,8}-C SUB,10}, MONOETILETER DIETILEN GLICOL Y MEZCLAS DE ELLOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT96BO000595A IT1286778B1 (it) | 1996-11-20 | 1996-11-20 | Capsule contenenti diclofenac o suoi sali in soluzione |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2184948T3 true ES2184948T3 (es) | 2003-04-16 |
Family
ID=11341728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97118047T Expired - Lifetime ES2184948T3 (es) | 1996-11-20 | 1997-10-17 | Capsulas que contienen diclofenaco o sus sales en forma de solucion. |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0845263B1 (es) |
AT (1) | ATE229332T1 (es) |
DE (1) | DE69717775T2 (es) |
DK (1) | DK0845263T3 (es) |
ES (1) | ES2184948T3 (es) |
IT (1) | IT1286778B1 (es) |
PT (1) | PT845263E (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2683020A1 (en) * | 2007-05-24 | 2008-11-27 | Novartis Ag | Oral dosage form providing fast absorption of drug |
FR2933871B1 (fr) * | 2008-07-18 | 2012-12-14 | Yvery | Formulation destinee a ameliorer la biodisponibilite d'une molecule hydrophobe |
AP2015008933A0 (en) * | 2009-04-24 | 2015-12-31 | Iceutica Pty Ltd | A novel formulation of diclofenac |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3328401A1 (de) * | 1983-08-05 | 1985-02-21 | Merckle GmbH, 7902 Blaubeuren | Injizierbare loesung zur behandlung von entzuendungen |
DE3446873A1 (de) * | 1984-12-21 | 1986-07-10 | Merckle Gmbh | Fluessige diclofenac-zubereitungen |
US5071643A (en) * | 1986-10-17 | 1991-12-10 | R. P. Scherer Corporation | Solvent system enhancing the solubility of pharmaceuticals for encapsulation |
IT1229489B (it) * | 1988-12-09 | 1991-09-03 | Altergon Sa | Composizioni farmaceutiche lipidiche per uso topico atte a veicolare un principio attivo antiinfiammatorio idrosolubile |
US5389681A (en) * | 1992-10-22 | 1995-02-14 | Ciba-Geigy Corporation | Parenteral solutions for diclofenac salts |
US5376688A (en) * | 1992-12-18 | 1994-12-27 | R. P. Scherer Corporation | Enhanced solubility pharmaceutical solutions |
-
1996
- 1996-11-20 IT IT96BO000595A patent/IT1286778B1/it active IP Right Grant
-
1997
- 1997-10-17 AT AT97118047T patent/ATE229332T1/de not_active IP Right Cessation
- 1997-10-17 PT PT97118047T patent/PT845263E/pt unknown
- 1997-10-17 DE DE69717775T patent/DE69717775T2/de not_active Expired - Fee Related
- 1997-10-17 DK DK97118047T patent/DK0845263T3/da active
- 1997-10-17 EP EP97118047A patent/EP0845263B1/en not_active Expired - Lifetime
- 1997-10-17 ES ES97118047T patent/ES2184948T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69717775D1 (de) | 2003-01-23 |
ITBO960595A0 (it) | 1996-11-20 |
DK0845263T3 (da) | 2003-03-31 |
ATE229332T1 (de) | 2002-12-15 |
IT1286778B1 (it) | 1998-07-17 |
ITBO960595A1 (it) | 1998-05-20 |
EP0845263B1 (en) | 2002-12-11 |
EP0845263A1 (en) | 1998-06-03 |
DE69717775T2 (de) | 2003-06-12 |
PT845263E (pt) | 2003-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59908771D1 (de) | Getränk zur steigerung der alkohol-abbau-kapazität | |
ES2032755T3 (es) | Medicamentos conteniendo hexadecil-fosfocolina con efecto antitumoral. | |
ES2111710T3 (es) | Proteasas que inhiben y desprenden el biofilm. | |
BR9714310A (pt) | Composição farmacêutica | |
DK139496B (da) | Natrium-svovlbatteri, især til kørselsformål. | |
NO860578L (no) | Tr¨d-ione-plasma elektron-kanon som anvender hjelpegitter. | |
ES2059786T3 (es) | Composicion blanqueante. | |
CO4750713A1 (es) | Macrolidos | |
ES2061546T3 (es) | Compuestos quelantes de piridoxamina, quelatos de manganeso (ii) y su uso como agentes de contraste de nmri. | |
ES2042794T3 (es) | Composiciones herbicidas. | |
DE19475001I2 (de) | Anthelminthische Wirkstoffkombinationen. | |
AR010716A1 (es) | Formulacion para tabletas efervecentes desinfectantes y metodo para formar una solucion desinfectante | |
ES2174293T3 (es) | Microesferas farmaceuticas de acido valproico para la administracion oral. | |
KR890004680A (ko) | 좌 약 | |
AR024959A1 (es) | Una composicion farmaceutica liquida basada en paracetamol | |
ES2011016B3 (es) | Composicion detergente liquida. | |
ES2184948T3 (es) | Capsulas que contienen diclofenaco o sus sales en forma de solucion. | |
ES2039040T3 (es) | Paramentos para movimientos de tierra. | |
ES2166900T3 (es) | Derivados de ara-c. | |
AR009120A1 (es) | Una composicion de grasa de urea y mecanismos que contienen tal composicion | |
SE8302979D0 (sv) | Piperazine derivatives, their production and pharmaceutical compositions containing them | |
SE8306225D0 (sv) | 2-piperazinyl-quinazoline derivatives, their production and pharmaceutical compositions containing them | |
ES2081463T3 (es) | 1-alquil-3-(acilamino)-epsilon-caprolactamas como mejoradores del aprendimiento y memoria y composiciones farmaceuticas que las contienen. | |
ES2196171T3 (es) | Agentes antitumorales de tioxantenona liofilizada. | |
ES2039251T3 (es) | Tratamiento del cabello. |